Clinical Trial

Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer

Study acronym: HY-PANC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-09; most recent amendment 2026-03-16.
Trial Details
NCT Number NCT07470268
Lead Sponsor Universidad Europea de Madrid
Conditions Pancreatic Cancer
Enrollment 10 participants
Start Date 2026-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-18